JinkoSolar (JKS) Announces 2 GW Distribution Contract for DG with Aldo Solar for 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil falls 1% as investors watch Middle East supply disruptions
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Pre-Open Stock Movers 11/30: (CPIX) (IMGN) (VIR) Higher; (JKS) (LIZI) (SEDG) Lower (more...)
November 30, 2021 9:28 AM ESTPre-Open Movers
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) 129% HIGHER; announced the U.S. Food and Drug Administration (FDA) has approved expanded labeling for Caldolor®, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration. The non-narcotic pain reliever may now be administered just prior to surgery to enable patients to wake up from their procedure in significantly less pain.
ImmunoGen Inc. (Nasdaq: IMGN) 45.5% HIGHER; announced positive top-line data from the pivotal SORAYA trial evaluating the safety and efficacy... More
JinkoSolar (JKS) Tops Q3 EPS by 6c
November 30, 2021 5:29 AM ESTJinkoSolar (NYSE: JKS) reported Q3 EPS of $0.08, $0.06 better than the analyst estimate of $0.02. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.34 billion.
GUIDANCE:
JinkoSolar sees Q4 2021 revenue of $1.8-2.2 billion, versus the consensus of $2.24... More
